Who are the key players in the Vaxchora Market Report 2026 market?

Major companies operating in the Vaxchora Market Report 2026 market are Major companies operating in the vaxchora market are Bavarian Nordic A/S Read More

What are the major opportunities in the Vaxchora market? What are the strategies for the Vaxchora market?

For detailed insights on the major opportunities and strategies in the Vaxchora market, Read More

How does the Vaxchora market relate to the overall economy and other similar markets?

For detailed insights on Vaxchora's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Vaxchora market growth? SWOT analysis of the Vaxchora market.

For detailed insights on the key dynamics influencing the Vaxchora market growth and SWOT analysis of the Vaxchora industry, Read More

Vaxchora Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Vaxchora Market Report 2026

Name: Vaxchora Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Epidemiology, Pipeline Analysis, Market Insights & Forecasts

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Vaxchora Market Overview

• The Vaxchora market growth in the historic period has been driven by increased international travelendemic regions, rising cholera outbreak preparedness measures

• Market expansion is supported by increasing investments in global disease prevention, rising demand for single-dose vaccines

• Growth Driver: Impact Of Rising Cholera Incidence On Vaccine Demand

• Market Trend: Expanding Regional Approvals To Enhance Cholera Prevention

• North America was the largest region in 2025.

What Is Covered Under Vaxchora Market?

Vaxchora is a vaccine used to prevent cholera, an infectious disease caused by the bacterium Vibrio cholerae. It is specifically approved for use in individuals aged 2 years and older traveling to areas where cholera is common. Vaxchora is recommended for adults aged 18 to 64 who are planning to visit regions where cholera is prevalent. The vaccine comes as a single-dose liquid, taken 10 days before potential contact with the bacteria.

The main clinical indications in the vaxchora market are prevention of cholera and prevention of gastrointestinal infections caused by vibrio cholerae. Prevention of Cholera refers to the process of avoiding the spread of vibrio cholerae, the bacteria responsible for causing cholera, through vaccination, sanitation, and safe water practices. Vaxchora is an oral vaccine used to prevent cholera by stimulating immunity against vibrio cholerae in individuals traveling to endemic areas. The various distribution channels include hospital pharmacies, retail pharmacies, online pharmacies, and travel pharmacies, and several end users including adult, pediatric, and geriatric.

Vaxchora Market Global Report 2026 Market Report bar graph

What Is The Vaxchora Market Size and Share 2026?

The growth in the historic period can be attributed to increased international travel to endemic regions, rising cholera outbreak preparedness measures, expansion of travel medicine clinics, regulatory approvals for oral vaccines, improved vaccine distribution frameworks.

What Is The Vaxchora Market Growth Forecast?

The growth in the forecast period can be attributed to increasing investments in global disease prevention, rising demand for single-dose vaccines, expansion of travel health services, growing focus on outbreak prevention strategies, increasing adoption in humanitarian and emergency response settings. Major trends in the forecast period include increasing demand for travel-related vaccines, rising awareness of cholera prevention, growing adoption of oral vaccine formats, expansion of global travel immunization programs, enhanced focus on rapid immunization compliance.

Book your 30 minutes free consultation with our research experts

Global Vaxchora Market Segmentation

1) By Clinical Indication: Prevention Of Cholera, Prevention Of Gastrointestinal Infections Caused By Vibrio Cholerae

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Travel Clinics

3) By End User: Adult, Pediatric, Geriatric

What Is The Driver Of The Vaxchora Market?

The rise in the incidence of cholera cases is expected to drive the growth of the vaxchora market going forward. Cholera is an infection caused by the vibrio cholerae bacterium, leading to severe diarrhea and dehydration from contaminated water or food. Cholera cases are rising due to factors such as inadequate sanitation, poor access to clean water, climate change, and increased population mobility to cholera-endemic regions. Vaxchora prevents cholera by stimulating the immune system to produce antibodies against Vibrio cholerae serogroup O1, reducing the risk of severe diarrhea and dehydration caused by cholera infection. For instance, in August 2025, according to the UK Health Security Agency UK-based government agency reported that In EWNI, 8 confirmed cholera cases were reported from January to June 2025, up from 1 case during the same period in 2024. Therefore, the rise in the incidence of cholera cases is driving the growth of the vaxchora industry.

Key Players In The Global Vaxchora Market

Major companies operating in the vaxchora market are Bavarian Nordic A/S

Global Vaxchora Market Trends and Insights

The key trend in the vaxchora market is expanded vaccination regional approvals to increase accessibility and cater to the growing demand for cholera prevention in endemic and high-risk areas. Expanded regional approvals help improve public health outcomes through broader immunization coverage and address the ever increasing global need for effective cholera prevention solutions. For example, in September 2024, Bavarian Nordic, a Denmark-based biotechnology company, announced the commercial availability of Vaxchora, the only single-dose oral vaccine approved in Canada to protect against cholera, a sudden and severe intestinal infection marked by acute watery diarrhea. The vaccine is delivered as a single oral dose and protects within 10 days.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Vaxchora Market?

In May 2023, Bavarian Nordic A/S, a Denmark-based biotechnology company, acquired travel vaccine portfolio from Emergent BioSolutions for $270 million. The acquisition includes two marketed vaccines, Vivotif for typhoid fever and Vaxchora for cholera, and a promising Phase III candidate for chikungunya, addressing critical unmet medical needs. This strategic move aims to strengthen Bavarian Nordic's position in the travel vaccine market while enhancing its research and development capabilities. Emergent BioSolutions is a US-based biotech company developing vaccines, including Vaxchora.

Regional Insights

North America was the largest region in the vaxchora market in 2025. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Vaxchora Market?

The vaxchora market consists of sales of oral cholera vaccines, vaccine administration supplies, and cold chain equipment. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Vaxchora Market Report 2026?

The vaxchora market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the vaxchora industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Vaxchora Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$ billion
Revenue Forecast In 2035	$ billion
Growth Rate	No CAGR found from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Clinical Indication, Distribution Channel, End User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Bavarian Nordic A/S
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Vaxchora Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Vaxchora Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Vaxchora Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Vaxchora Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Sustainability, Climate Tech & Circular Economy

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Digitalization, Cloud, Big Data & Cybersecurity

4.1.5 Artificial Intelligence & Autonomous Intelligence

4.2. Major Trends

4.2.1 Increasing Demand For Travel-Related Vaccines

4.2.2 Rising Awareness Of Cholera Prevention

4.2.3 Growing Adoption Of Oral Vaccine Formats

4.2.4 Expansion Of Global Travel Immunization Programs

4.2.5 Enhanced Focus On Rapid Immunization Compliance

5. Vaxchora Market Analysis Of End Use Industries

5.1 Travel Clinics

5.2 Hospitals

5.3 Infectious Disease Clinics

5.4 Public Health Agencies

5.5 Travel Medicine Providers

6. Vaxchora Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Vaxchora Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Vaxchora PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Vaxchora Market Size, Comparisons And Growth Rate Analysis

7.3. Global Vaxchora Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Vaxchora Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Vaxchora Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Vaxchora Market Segmentation

9.1. Global Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Prevention Of Cholera, Prevention Of Gastrointestinal Infections Caused By Vibrio Cholerae

9.2. Global Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Travel Clinics

9.3. Global Vaxchora Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Adult, Pediatric, Geriatric

10. Vaxchora Market Regional And Country Analysis

10.1. Global Vaxchora Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Vaxchora Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Vaxchora Market

11.1. Asia-Pacific Vaxchora Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Vaxchora Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Vaxchora Market

12.1. China Vaxchora Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Vaxchora Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Vaxchora Market

13.1. India Vaxchora Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Vaxchora Market

14.1. Japan Vaxchora Market Overview

14.2. Japan Vaxchora Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Vaxchora Market

15.1. Australia Vaxchora Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. South Korea Vaxchora Market

16.1. South Korea Vaxchora Market Overview

16.2. South Korea Vaxchora Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Western Europe Vaxchora Market

17.1. Western Europe Vaxchora Market Overview

17.2. Western Europe Vaxchora Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. UK Vaxchora Market

18.1. UK Vaxchora Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Germany Vaxchora Market

19.1. Germany Vaxchora Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. France Vaxchora Market

20.1. France Vaxchora Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Eastern Europe Vaxchora Market

21.1. Eastern Europe Vaxchora Market Overview

21.2. Eastern Europe Vaxchora Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. North America Vaxchora Market

22.1. North America Vaxchora Market Overview

22.2. North America Vaxchora Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. USA Vaxchora Market

23.1. USA Vaxchora Market Overview

23.2. USA Vaxchora Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Canada Vaxchora Market

24.1. Canada Vaxchora Market Overview

24.2. Canada Vaxchora Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. South America Vaxchora Market

25.1. South America Vaxchora Market Overview

25.2. South America Vaxchora Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Middle East Vaxchora Market

26.1. Middle East Vaxchora Market Overview

26.2. Middle East Vaxchora Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Africa Vaxchora Market

27.1. Africa Vaxchora Market Overview

27.2. Africa Vaxchora Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Vaxchora Market Regulatory and Investment Landscape

29. Vaxchora Market Competitive Landscape And Company Profiles

29.1. Vaxchora Market Competitive Landscape And Market Share 2024

29.1.1. Top 10 Companies (Ranked by revenue/share)

29.2. Vaxchora Market - Company Scoring Matrix

29.2.1. Market Revenues

29.2.2. Product Innovation Score

29.2.3. Brand Recognition

29.3. Vaxchora Market Company Profiles

29.3.1. Bavarian Nordic A/S Overview, Products and Services, Strategy and Financial Analysis

30. Global Vaxchora Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Vaxchora Market

32. Vaxchora Market High Potential Countries, Segments and Strategies

32.1 Vaxchora Market In 2030 - Countries Offering Most New Opportunities

32.2 Vaxchora Market In 2030 - Segments Offering Most New Opportunities

32.3 Vaxchora Market In 2030 - Growth Strategies

32.3.1 Market Trend Based Strategies

32.3.2 Competitor Strategies

33. Appendix

33.1. Abbreviations

33.2. Currencies

33.3. Historic And Forecast Inflation Rates

33.4. Research Inquiries

33.5. The Business Research Company

33.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Vaxchora Market, Overview Of Key Products - Product Examples

Table 2: Global Vaxchora Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Vaxchora Market, Supply Chain Analysis

Table 4: Global Vaxchora Market, Major Raw Material Providers

Table 5: Global Vaxchora Market, Major Resource Providers

Table 6: Global Vaxchora Market, Major Manufacturers (Suppliers)

Table 7: Global Vaxchora Market, Major Distributors And Channel Partners

Table 8: Global Vaxchora Market, Key Technologies & Future Trends

Table 9: Global Vaxchora Market, Major Trends

Table 10: Global Vaxchora Market, Major End Users

Table 11: Global Vaxchora Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Vaxchora Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Vaxchora Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Vaxchora Market - TAM, US$ Billion, 2025

Table 15: Global Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Vaxchora Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Vaxchora Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Vaxchora Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Asia-Pacific, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Asia-Pacific, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Asia-Pacific, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: China, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: China, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: China, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: India, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: India, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: India, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: Japan, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: Japan, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: Japan, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: Australia, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Australia, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Australia, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: South Korea, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: South Korea, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: South Korea, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Western Europe, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Western Europe, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Western Europe, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: UK, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: UK, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: UK, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Germany, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Germany, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Germany, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: France, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: France, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: France, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Eastern Europe, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Eastern Europe, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Eastern Europe, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: North America, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: North America, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: North America, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: USA, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: USA, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: USA, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Canada, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Canada, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Canada, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: South America, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: South America, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: South America, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Middle East, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Middle East, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Middle East, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Africa, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Africa, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Africa, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Global Vaxchora Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 72: Global Vaxchora Market - Company Scoring Matrix

Table 73: Bavarian Nordic A/S Financial Performance

Table 74: Global Vaxchora Market, Competitive Benchmarking (In USD Billions)

Table 75: Global Vaxchora Market, Competitive Dashboard

Table 76: Global Vaxchora Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 77: Global, Vaxchora Market Size Gain ($ Billion), Segmentation By Clinical Indication, 2025 – 2030

Table 78: Global, Vaxchora Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Table 79: Global, Vaxchora Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

List Of Figures

Figure 1: Global Vaxchora Market, Overview Of Key Products - Product Examples

Figure 2: Global Vaxchora Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Vaxchora Market, Supply Chain Analysis

Figure 4: Global Vaxchora Market, Major Raw Material Providers

Figure 5: Global Vaxchora Market, Major Resource Providers

Figure 6: Global Vaxchora Market, Major Manufacturers (Suppliers)

Figure 7: Global Vaxchora Market, Major Distributors And Channel Partners

Figure 8: Global Vaxchora Market, Key Technologies & Future Trends

Figure 9: Global Vaxchora Market, Major Trends

Figure 10: Global Vaxchora Market, Major End Users

Figure 11: Global Vaxchora Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Vaxchora Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Vaxchora Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Vaxchora Market - TAM, US$ Billion, 2025

Figure 15: Global Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Vaxchora Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Vaxchora Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Vaxchora Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Asia-Pacific, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Asia-Pacific, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Asia-Pacific, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: China, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: China, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: China, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: India, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: India, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: India, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: Japan, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: Japan, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: Japan, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: Australia, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Australia, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Australia, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: South Korea, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: South Korea, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: South Korea, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Western Europe, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Western Europe, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Western Europe, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: UK, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: UK, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: UK, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Germany, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Germany, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Germany, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: France, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: France, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: France, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Eastern Europe, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Eastern Europe, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Eastern Europe, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: North America, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: North America, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: North America, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: USA, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: USA, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: USA, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Canada, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Canada, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Canada, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: South America, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: South America, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: South America, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Middle East, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Middle East, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Middle East, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Africa, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Africa, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Africa, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Global Vaxchora Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 72: Global Vaxchora Market - Company Scoring Matrix

Figure 73: Bavarian Nordic A/S Financial Performance

Figure 74: Global Vaxchora Market, Competitive Benchmarking (In USD Billions)

Figure 75: Global Vaxchora Market, Competitive Dashboard

Figure 76: Global Vaxchora Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 77: Global, Vaxchora Market Size Gain ($ Billion), Segmentation By Clinical Indication, 2025 – 2030

Figure 78: Global, Vaxchora Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Figure 79: Global, Vaxchora Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Peripheral Vasodilator Drugs Market Report 2026 - Global Outlook – By Drug Type (Calcium Channel Blockers, Direct-Acting Vasodilators, Alpha-Adrenergic Blockers, Potassium Channel Activators, Nitrates, Other Types), By I...

Biopreservation Market Report 2026 - Global Outlook – By Type (Biopreservation Equipment, Biopreservation Media), By Biospecimen (Human Tissue Samples, Organs, Stem Cells, Other Biospecimens), By Application (Therapeutic...

Data Lake Market Report 2026 - Global Outlook – By Type (Solution, Services), By Deployment (On-Premise, Cloud), By Organization Size (Large Enterprises, Small And Medium-Sized Enterprises (SMEs)), By Vertical (Informati...

Vertical Market Software Market Report 2026 - Global Outlook – By Software Type (Banking Software, Education Software, Legal Software, Agriculture Software, Alumni Management Software, Amusement Park Software, Apparel So...

Luxury Resale Market Report 2026 - Global Outlook – By Type (Apparel And Accessories, Watches, Fine Jewelry, Leather Goods, Other Types), By Demographic (Men, Women, Unisex), By Distribution (Online Platforms, Brick-and-...

Vanadium Market Report 2026 - Global Outlook – By Type (Vanadium Pentoxide, Vanadium Ferrovanadium, Aluminum-Vanadium Alloys, Vanadium Chemicals, Other Types), By Production Process (Aluminothermic Reduction Technique, S...

SLS and LABSA Market Report 2026 - Global Outlook – By Product Type (Sodium Lauryl Sulfate (SLS), Linear Alkyl Benzene Sulfonic Acid (LABSA)), By Function (Cleansing, Emulsifying, Wetting), By Application (Personal Care,...

Frequently Asked Questions

How big is the Vaxchora Market?

The Vaxchora market was valued at $ billion in 2025, increased to $ billion in 2026, and is projected to reach $ billion by 2030.

What is the Vaxchora market growth?

The global Vaxchora market is expected to grow at a CAGR of nan% from 2026 to 2035 to reach $ billion by 2035.

Who are the key players in Vaxchora market?

Some Key Players in the Vaxchora market Include, Bavarian Nordic A/S .

What is the anticipated growth trend for the Vaxchora market?

Major trend in this market includes: Expanding Regional Approvals To Enhance Cholera Prevention. For further insights on this market. request a sample here

Which region has the most growth potential in the Vaxchora market?

North America was the largest region in the vaxchora market in 2025. The regions covered in the vaxchora market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.